Home » Topics » Regulatory

Regulatory
RSS

FDA clears potent pain reliever without opioid side effects from Wyeth-Ayerst

July 24, 1997

No Comments

Teva's generic antihypertensive combination tentatively approved

July 23, 1997

No Comments

U.K. approves Astra's treatment for ulcerative colitis

July 23, 1997

No Comments

Prograf to be submitted in Japan for atopic dermatitis

July 22, 1997

No Comments

TAP receives FDA approval to market new formulation of Lupron Depot

July 21, 1997

No Comments

Rogaine Extra Strength for Men recommended for approval as OTC

July 21, 1997

No Comments

FDA clears new indication and new labeling for Zoloft

July 18, 1997

No Comments

Ganciclovir implant effective in treating CMV retinitis

July 17, 1997

No Comments

RPR launches room-temperature formulation of DDAVP

July 16, 1997

No Comments

Athena Neurosciences and Wyeth-Ayerst copromote Naprelan

July 16, 1997

No Comments

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Regulatory
RSS

FDA clears potent pain reliever without opioid side effects from Wyeth-Ayerst

Teva's generic antihypertensive combination tentatively approved

U.K. approves Astra's treatment for ulcerative colitis

Prograf to be submitted in Japan for atopic dermatitis

TAP receives FDA approval to market new formulation of Lupron Depot

Rogaine Extra Strength for Men recommended for approval as OTC

FDA clears new indication and new labeling for Zoloft

Ganciclovir implant effective in treating CMV retinitis

RPR launches room-temperature formulation of DDAVP

Athena Neurosciences and Wyeth-Ayerst copromote Naprelan

Today's news in brief

Myelin damaged by multiple sclerosis could be repaired by reducing levels of an enzyme

Today's news in brief

Quite a fix: Orthofix sacks three top execs

Challenges in China spell trouble for Illumina, 10x and others

Regulatory RSS

Regulatory
RSS